Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for Multiple Sclerosis
NCT00004744Phase 3Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Feb 1993
- Primary completion
- Sep 1998
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of Human normal immunoglobulin G in multiple sclerosis (MS), sponsored by National Institute of Neurological Disorders and Stroke. Started Feb 1993; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00004744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004744.